Zentalis Pharmaceuticals | 144:拟议出售证券
Zentalis Pharmaceuticals | 4:持股变动声明-高管 HAUSMAN DIANA
Zentalis Pharmaceuticals | 10-Q:季度报表
Zentalis Pharmaceuticals | 8-K:Zentalis Pharmicals公布2024年第一季度财务业绩和运营进展
Zentalis Pharmaceuticals | DEFA14A:其他
Zentalis Pharmaceuticals | DEF 14A:股东委托书决议
Zentalis Pharmaceuticals | ARS:年度报告
Zentalis Pharmaceuticals | 3:首次持股声明-高管 Vultaggio Vincent
Zentalis Pharmaceuticals | 8-K:重大事件
Zentalis Pharmaceuticals | 8-K:重大事件
Zentalis Pharmaceuticals | S-8:员工福利计划证券登记
Zentalis Pharmaceuticals | S-3ASR:“知名成熟发行人”证券注册声明
Zentalis Pharmaceuticals | 10-K:年度报表
Zentalis Pharmaceuticals | 8-K:重大事件
Zentalis Pharmaceuticals | 8-K:重大事件
Zentalis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Kenneth Griffin(5.3%),Citadel Advisors LLC(5.1%)等
Zentalis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(7.56%)
Zentalis Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Avidity Partners Management LP(0%),Avidity Partners Management (GP) LLC(0%)等
Zentalis Pharmaceuticals | 144:拟议出售证券
Zentalis Pharmaceuticals | 144:拟议出售证券
暂无数据